Similar articles

• Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?

  Kurtz JM. Kurtz JM. Strahlenther Onkol. 2000 Sep;176(9):433-4. Strahlenther Onkol. 2000. PMID: 11050918 No abstract available.
• BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.

  Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H. Yazici H, et al. Br J Cancer. 2000 Sep;83(6):737-42. doi: 10.1054/bjoc.2000.1332. Br J Cancer. 2000. PMID: 10952777 Free PMC article.
• Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.

  Claes K, Machackova E, De Vos M, Mortier G, De Paepe A, Messiaen L. Claes K, et al. Hum Mutat. 1999;13(3):256. doi: 10.1002/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M. Hum Mutat. 1999. PMID: 10090482
• [Genetic diagnosis of hereditary breast cancer].

  Yano K, Miki Y. Yano K, et al. Nihon Rinsho. 2000 Apr;58 Suppl:527-32. Nihon Rinsho. 2000. PMID: 11026044 Review. Japanese. No abstract available.
• [Is hereditary predisposition to breast cancer linked to BRCA1 a disease of response to genotoxic lesions?].

  Feunteun J. Feunteun J. C R Seances Soc Biol Fil. 1998;192(2):235-40. C R Seances Soc Biol Fil. 1998. PMID: 9759367 Review. French.